Literature DB >> 12668873

Aldolase C/zebrin gene regulation by prolactin during pregnancy and lactation.

Manabu Matsuda1, Jason A Lockefeer, Nelson D Horseman.   

Abstract

Prolactin (PRL) is necessary for the genesis of mammary alveolar buds and for lactation. A cDNA library enriched for PRL-dependent genes was made by suppression subtractive hybridization. Aldolase C/zebrin (AldC/zebrin), a brain-specific aldolase, was found to be PRL-dependent in the mouse mammary glands. AldC/zebrin was preferentially expressed in the alveolar buds. Expression of the gene in the ovary was also evident. During pregnancy, mammary AldC/zebrin mRNA levels were elevated beginning at midpregnancy (d 10 of pregnancy) in accordance with the genesis of the lobuloalveolar system, and the expression level was gradually increased through the end of pregnancy. Lactating mammary gland contained a very high level of AldC/zebrin mRNA, and the gene expression decreased during involution. By contrast, levels of aldolase A and B mRNA expression in the mammary glands were less affected by pregnancy and lactation. The selective regulation of AldC/zebrin may contribute to a shift in nutrient metabolism during pregnancy and lactation to facilitate epithelial growth and biosynthesis of milk constituents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668873     DOI: 10.1385/ENDO:20:1-2:91

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  31 in total

Review 1.  Mammary gland development in prolactin receptor knockout mice.

Authors:  C J Ormandy; N Binart; P A Kelly
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

2.  Verification of differential gene transcription using virtual northern blotting.

Authors:  O Franz; I Bruchhaus; T Roeder
Journal:  Nucleic Acids Res       Date:  1999-06-01       Impact factor: 16.971

Review 3.  The anterior pituitary-grafted rat: a valid model of chronic hyperprolactinemia.

Authors:  R A Adler
Journal:  Endocr Rev       Date:  1986-08       Impact factor: 19.871

Review 4.  Receptor activator of nuclear factor kappa B ligand (RANKL): another link between breast and bone.

Authors:  T J Martin; M T Gillespie
Journal:  Trends Endocrinol Metab       Date:  2001 Jan-Feb       Impact factor: 12.015

5.  Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth.

Authors:  A J Vomachka; S L Pratt; J A Lockefeer; N D Horseman
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

Review 6.  Bone mineral changes during pregnancy and lactation.

Authors:  Heidi J Kalkwarf; Bonny L Specker
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

7.  The mRNA expression of neurocan, a brain-specific chondroitin sulfate proteoglycan, in neoplastic mammary glands in mice.

Authors:  T Harigaya; H Ogawa; S Tsunoda; H Nagasawa
Journal:  Zoolog Sci       Date:  1996-10       Impact factor: 0.931

8.  Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse.

Authors:  C J Ormandy; A Camus; J Barra; D Damotte; B Lucas; H Buteau; M Edery; N Brousse; C Babinet; N Binart; P A Kelly
Journal:  Genes Dev       Date:  1997-01-15       Impact factor: 11.361

9.  Neuroendocrine and reproductive functions in male mice with targeted disruption of the prolactin gene.

Authors:  R W Steger; V Chandrashekar; W Zhao; A Bartke; N D Horseman
Journal:  Endocrinology       Date:  1998-09       Impact factor: 4.736

10.  Enzyme relationships in a sorbitol pathway that bypasses glycolysis and pentose phosphates in glucose metabolism.

Authors:  J Jeffery; H Jörnvall
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

View more
  1 in total

Review 1.  Key stages in mammary gland development. Secretory activation in the mammary gland: it's not just about milk protein synthesis!

Authors:  Steven M Anderson; Michael C Rudolph; James L McManaman; Margaret C Neville
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.